Cargando…
Hepatitis B and C in dialysis units in Kosova
BACKGROUND: Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are important causes of morbidity and mortality of hemodialysis (HD) patients. This study aimed to investigate the epidemiological and clinical features of HCV and HBV infections in six different HD units in Kosova. Five hund...
Autores principales: | , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2694791/ https://www.ncbi.nlm.nih.gov/pubmed/19497116 http://dx.doi.org/10.1186/1743-422X-6-72 |
_version_ | 1782168123534737408 |
---|---|
author | Telaku, Skender Fejza, Hajrullah Elezi, Ymer Bicaj, Teuta |
author_facet | Telaku, Skender Fejza, Hajrullah Elezi, Ymer Bicaj, Teuta |
author_sort | Telaku, Skender |
collection | PubMed |
description | BACKGROUND: Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are important causes of morbidity and mortality of hemodialysis (HD) patients. This study aimed to investigate the epidemiological and clinical features of HCV and HBV infections in six different HD units in Kosova. Five hundred and eighty-three end-stage kidney disease (ESKD) patients on maintenance HD from six HD centers in Kosova (358 female, 225 male, mean age 54,8 years (16–66) were included in this study. Data from databank of the National Blood Bank in Prishtina, as well as the data from the databank of the Transfusion Centers in Regional hospitals in Prizren, Peja, Gjilan, Mitrovica and Gjakova were taken in this study. Clinical data such as age, sex, HBsAg and anti-HCV antibody and primary causes of ESKD were examined. Serological markers for HBV and HCV were determined with immunoenzymatic assay (ELISA). RESULTS: The T-test and x(2 )test were used to analyze the significance of the results. Among our HD patients HBsAg and anti-HCV antibody prevalence rate was 12%, respectively 43%. Chronic nephritis was a more frequent cause of ESKD among our HD patients. With unknown etiology were 23, 5% from them. CONCLUSION: HBV and HCV prevalence in our HD patients is still high. These data emphasize the need for stricter adherence to infection control, barrier precaution and preventive behaviors with all patients. |
format | Text |
id | pubmed-2694791 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-26947912009-06-11 Hepatitis B and C in dialysis units in Kosova Telaku, Skender Fejza, Hajrullah Elezi, Ymer Bicaj, Teuta Virol J Research BACKGROUND: Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are important causes of morbidity and mortality of hemodialysis (HD) patients. This study aimed to investigate the epidemiological and clinical features of HCV and HBV infections in six different HD units in Kosova. Five hundred and eighty-three end-stage kidney disease (ESKD) patients on maintenance HD from six HD centers in Kosova (358 female, 225 male, mean age 54,8 years (16–66) were included in this study. Data from databank of the National Blood Bank in Prishtina, as well as the data from the databank of the Transfusion Centers in Regional hospitals in Prizren, Peja, Gjilan, Mitrovica and Gjakova were taken in this study. Clinical data such as age, sex, HBsAg and anti-HCV antibody and primary causes of ESKD were examined. Serological markers for HBV and HCV were determined with immunoenzymatic assay (ELISA). RESULTS: The T-test and x(2 )test were used to analyze the significance of the results. Among our HD patients HBsAg and anti-HCV antibody prevalence rate was 12%, respectively 43%. Chronic nephritis was a more frequent cause of ESKD among our HD patients. With unknown etiology were 23, 5% from them. CONCLUSION: HBV and HCV prevalence in our HD patients is still high. These data emphasize the need for stricter adherence to infection control, barrier precaution and preventive behaviors with all patients. BioMed Central 2009-06-04 /pmc/articles/PMC2694791/ /pubmed/19497116 http://dx.doi.org/10.1186/1743-422X-6-72 Text en Copyright © 2009 Telaku et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Telaku, Skender Fejza, Hajrullah Elezi, Ymer Bicaj, Teuta Hepatitis B and C in dialysis units in Kosova |
title | Hepatitis B and C in dialysis units in Kosova |
title_full | Hepatitis B and C in dialysis units in Kosova |
title_fullStr | Hepatitis B and C in dialysis units in Kosova |
title_full_unstemmed | Hepatitis B and C in dialysis units in Kosova |
title_short | Hepatitis B and C in dialysis units in Kosova |
title_sort | hepatitis b and c in dialysis units in kosova |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2694791/ https://www.ncbi.nlm.nih.gov/pubmed/19497116 http://dx.doi.org/10.1186/1743-422X-6-72 |
work_keys_str_mv | AT telakuskender hepatitisbandcindialysisunitsinkosova AT fejzahajrullah hepatitisbandcindialysisunitsinkosova AT eleziymer hepatitisbandcindialysisunitsinkosova AT bicajteuta hepatitisbandcindialysisunitsinkosova |